News
-
29 October 2020
Boehringer initiates trial of targeted therapy to treat Covid-19 patients
Boehringer Ingelheim has initiated a Phase II clinical trial of a novel compound, BI 764198, for treating hospitalised Covid-19 patients with acute respiratory complications.
-
28 October 2020
Aurinia initiates voclosporin trial in KTRs with Covid-19
Aurinia Pharmaceuticals has initiated an open-label exploratory trial to analyse the antiviral effects of voclosporin in kidney transplant recipients (KTRs) with Covid-19.
-
28 October 2020
Olatec Therapeutics initiates enrolment in oral drug trial for Covid-19
Olatec Therapeutics has initiated patient enrolment in a Phase II trial to analyse the safety and efficacy of oral NLRP3 inhibitor, dapansutrile, for treating patients with moderate Covid-19 symptoms and...
-
27 October 2020
HiFiBiO Therapeutics concludes first cohort of Covid-19 antibody study
HiFiBiO Therapeutics has successfully completed the first cohort of the Phase I trial (NCT04590430) of SARS-CoV-2 neutralising antibody, HFB30132A, to treat Covid-19.
-
26 October 2020
Israel to initiate human trials of potential Covid-19 vaccine
The Israel Institute for Biological Research (IIBR) has obtained regulatory approval to initiate human clinical trials for its Covid-19 vaccine candidate on 1 November.
-
23 October 2020
Moderna completes enrolment for mRNA-1273 trial against Covid-19
Moderna has completed the enrolment of participants for the Phase III COVE study of its vaccine candidate, mRNA-1273, against Covid-19.
-
22 October 2020
Participant in AstraZeneca’s Brazilian Covid-19 trial dies
Brazilian health agency Anvisa has announced that a volunteer in the Brazilian trial of AstraZeneca and Oxford University’s investigational Covid-19 vaccine has died, but the trial is expected to continue.
-
21 October 2020
Appili Therapeutics doses first patients in Covid-19 clinical trial
Canada-based Appili Therapeutics has enrolled and dosed the first cluster of participants in its Phase II CONTROL COVID-19 clinical trial of favipiravir.
-
20 October 2020
Pfizer and BioNTech initiate trials of Covid-19 vaccine in Japan
Pfizer and BioNTech have begun combined Phase I and Phase II clinical trials of their mRNA vaccine candidate against Covid-19 in Japan.
-
19 October 2020
Chinese Covid-19 vaccine shows promising results in Phase I/II trial
A potential Covid-19 vaccine being developed by China National Biotech Group (CNBG) unit Beijing Institute of Biologic Products demonstrated to be safe and triggered immune responses in a combined early...